Literature DB >> 20652677

[Continuing medical education in systemic treatment : Are the contents adequately conveyed?].

J E Gschwend1.   

Abstract

Continuing medical education for systemic treatment has become an essential requirement for urologists to take part in treating oncology patients as part of the new oncology directive. Apart from this, urologists working in clinical facilities are more frequently being assessed according to how well they can document their professional qualifications for the entire field of uro-oncology, i.e., surgical and systemic therapy. The increasing interdisciplinary centralization of managing oncology patients in comprehensive cancer centers, oncology centers, and collaborative associations for urology necessitates a high level of specialization with regard to form and content. All urologists in Germany are called upon to confront this challenge, avail themselves of the opportunities for continuing education, and acquire the requisite accreditation.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20652677     DOI: 10.1007/s00120-010-2305-9

Source DB:  PubMed          Journal:  Urologe A        ISSN: 0340-2592            Impact factor:   0.639


  2 in total

1.  [Additional classification "medicinal tumor therapy": statement by the German Society of Residents in Urology (GeSRU)].

Authors:  M Neuhäuser; S Schöne; M Meilinger; C Ruf; A Martinschek
Journal:  Urologe A       Date:  2012-05       Impact factor: 0.639

2.  "We talk it over"--mixed-method study of interdisciplinary collaborations in private practice among urologists and oncologists in Germany.

Authors:  Sandra Beermann; Denny Chakkalakal; Rebecca Muckelbauer; Lothar Weißbach; Christine Holmberg
Journal:  BMC Cancer       Date:  2014-10-04       Impact factor: 4.430

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.